• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经酰胺通过诱导p105的加工过程来激活核因子κB。

Ceramide activates NFkappaB by inducing the processing of p105.

作者信息

Boland M P, O'Neill L A

机构信息

Department of Biochemistry, Trinity College, Dublin 2, Ireland.

出版信息

J Biol Chem. 1998 Jun 19;273(25):15494-500. doi: 10.1074/jbc.273.25.15494.

DOI:10.1074/jbc.273.25.15494
PMID:9624136
Abstract

The role of ceramide as a second messenger in tumor necrosis factor (TNF)-mediated signal transduction has been much debated. It is supported by recent reports describing an expanding number of potential targets for this lipid, but is opposed by those describing how ceramide is not necessary for many TNF-mediated cellular events. In this paper, we directly compare the effects of the cell-permeable ceramide analogue, N-acetylsphingosine (C2-ceramide), with TNF, on NFkappaB function, a transcription factor whose activation is central to many TNF-mediated effects. We describe how C2-ceramide failed to drive kappaB-linked chloramphenicol acetyltransferase gene expression in either HL60 promyelocytic or Jurkat T lymphoma cells. Furthermore, it had no effect on TNF-mediated transcription of this reporter gene. However, electrophoretic mobility shift analysis following cell stimulation with this ceramide analogue revealed a dose-responsive activation of NFkappaB, which was not apparent following cell treatment with the inactive dihydro form. Activated complexes from treated cells were shown to contain predominantly the p50 subunit, in contrast to complexes from TNF-treated cells, where both p50 and p65/RelA subunits were present. The specific activation of p50 homodimeric complexes by C2-ceramide, which are known to lack trans-activating activity, was strongly suggested from these data. Further investigations revealed that C2-ceramide had only a marginal effect on IkappaBalpha degradation but strongly promoted the processing of p105 to its p50 product as revealed by immunoblot analysis. The increase in p50 arising from the processing of its p105 precursor was further established from p105/p50 ratios obtained by scanning densitometric analysis of bands from immunoblots. TNF, on the other hand, stimulated both IkappaBalpha degradation and p105 processing, in accordance with previous findings. Furthermore, the effect of TNF on NFkappaB activation was rapid, whereas C2-ceramide required an optimal treatment time of 1 h. Interestingly, TNF was found to increase ceramide in cells but only after a 1-h contact time. Our data therefore suggest that ceramide promotes the activation of NFkappaB complexes that lack transactivating activity by enhanced processing of p105.

摘要

神经酰胺作为肿瘤坏死因子(TNF)介导的信号转导中的第二信使,其作用一直备受争议。近期报告称这种脂质的潜在靶点数量不断增加,这支持了该观点,但也有报告称神经酰胺对许多TNF介导的细胞事件并非必需,这又对此观点表示反对。在本文中,我们直接比较了细胞可渗透的神经酰胺类似物N - 乙酰鞘氨醇(C2 - 神经酰胺)与TNF对NFκB功能的影响,NFκB是一种转录因子,其激活对许多TNF介导的效应至关重要。我们描述了C2 - 神经酰胺在HL60早幼粒细胞或Jurkat T淋巴瘤细胞中均未能驱动κB连接的氯霉素乙酰转移酶基因表达。此外,它对该报告基因的TNF介导转录没有影响。然而,用这种神经酰胺类似物刺激细胞后进行的电泳迁移率变动分析显示NFκB呈剂量反应性激活,而用无活性的二氢形式处理细胞后则未出现这种情况。与TNF处理的细胞中的复合物不同,处理过的细胞中的活化复合物主要含有p50亚基,TNF处理的细胞中的复合物同时存在p50和p65/RelA亚基。这些数据强烈表明C2 - 神经酰胺特异性激活了已知缺乏反式激活活性的p50同二聚体复合物。进一步研究表明,C2 - 神经酰胺对IκBα降解的影响很小,但通过免疫印迹分析显示它强烈促进了p105向其p50产物的加工。通过对免疫印迹条带进行扫描光密度分析获得的p105/p50比值进一步证实了由p105前体加工产生的p50增加。另一方面,TNF如先前发现的那样,刺激了IκBα降解和p105加工。此外,TNF对NFκB激活的作用迅速,而C2 - 神经酰胺需要1小时的最佳处理时间。有趣的是,发现TNF仅在接触1小时后才会增加细胞中的神经酰胺。因此,我们的数据表明神经酰胺通过增强p105的加工促进了缺乏反式激活活性的NFκB复合物的激活。

相似文献

1
Ceramide activates NFkappaB by inducing the processing of p105.神经酰胺通过诱导p105的加工过程来激活核因子κB。
J Biol Chem. 1998 Jun 19;273(25):15494-500. doi: 10.1074/jbc.273.25.15494.
2
NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.核因子-κB p105是IκB激酶的作用靶点,并控制Bcl-3-p50复合物的信号诱导。
EMBO J. 1999 Sep 1;18(17):4766-78. doi: 10.1093/emboj/18.17.4766.
3
Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.IκB激酶诱导的SCF(βTrCP)介导的NF-κB前体p105和IκBα泛素化及降解的共享途径。
Mol Cell Biol. 2001 Feb;21(4):1024-35. doi: 10.1128/MCB.21.4.1024-1035.2001.
4
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.乙型肝炎病毒X蛋白通过作用于rel相关蛋白的多种细胞质抑制剂来激活转录因子核因子κB。
J Virol. 1996 Jul;70(7):4558-66. doi: 10.1128/JVI.70.7.4558-4566.1996.
5
TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.TPL-2激酶调节核因子κB抑制蛋白NF-κB1 p105的蛋白水解。
Nature. 1999 Jan 28;397(6717):363-8. doi: 10.1038/16946.
6
Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells.柔红霉素激活核因子κB并在HL-60早幼粒细胞和Jurkat T淋巴瘤细胞中诱导κB依赖性基因表达。
J Biol Chem. 1997 May 16;272(20):12952-60. doi: 10.1074/jbc.272.20.12952.
7
Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.含锚蛋白基序的多种细胞质抑制剂对核因子-κB反式激活因子RelA(p65)的自动调节
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1346-50. doi: 10.1073/pnas.91.4.1346.
8
Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.人类核因子κB p50/p105基因的启动子。受核因子κB亚基和c-REL调控。
J Immunol. 1993 Apr 1;150(7):2794-804.
9
Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells.糖皮质激素对成骨样ROS17/2.8细胞中肿瘤坏死因子α依赖性核因子κB激活及细胞间黏附分子1基因表达的影响。
J Bone Miner Res. 2000 Sep;15(9):1707-15. doi: 10.1359/jbmr.2000.15.9.1707.
10
Characterization of ES cells deficient for the p105 precursor (NF-kappa B1): role of p50 NLS.p105前体(NF-κB1)缺陷的胚胎干细胞的特征:p50核定位信号的作用
Oncogene. 1996 Jul 18;13(2):255-63.

引用本文的文献

1
Effects of Milk Polar Lipids on DSS-Induced Colitis Severity Are Dependent on Dietary Fat Content.牛奶极性脂对 DSS 诱导结肠炎严重程度的影响取决于膳食脂肪含量。
Nutrients. 2022 Dec 3;14(23):5145. doi: 10.3390/nu14235145.
2
The role of lipids in autophagy and its implication in neurodegeneration.脂质在自噬中的作用及其与神经退行性变的关联。
Cell Stress. 2020 May 19;4(7):167-186. doi: 10.15698/cst2020.07.225.
3
The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration.
鞘脂类与胰岛素样生长因子信号的串扰:与衰老和神经退行性变的关系。
Mol Neurobiol. 2019 May;56(5):3501-3521. doi: 10.1007/s12035-018-1286-3. Epub 2018 Aug 23.
4
New concepts in white adipose tissue physiology.白色脂肪组织生理学的新概念。
Braz J Med Biol Res. 2014 Feb;47(3):192-205. doi: 10.1590/1414-431X20132911. Epub 2014 Feb 18.
5
Transcriptional impact of dietary methionine restriction on systemic inflammation: relevance to biomarkers of metabolic disease during aging.饮食中蛋氨酸限制对全身炎症的转录影响:与衰老过程中代谢疾病生物标志物的相关性。
Biofactors. 2014 Jan-Feb;40(1):13-26. doi: 10.1002/biof.1111. Epub 2013 Jun 29.
6
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.2 型糖尿病患者的 LDL 中所含的神经酰胺水平升高,会促进炎症和骨骼肌胰岛素抵抗。
Diabetes. 2013 Feb;62(2):401-10. doi: 10.2337/db12-0686. Epub 2012 Nov 8.
7
Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes.激活 AMP 激活的蛋白激酶可预防视网膜周细胞的脂毒性。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3630-9. doi: 10.1167/iovs.10-5784.
8
Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice.血小板活化因子诱导核因子-κB p105加工成p50,后者介导小鼠急性肠道损伤。
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G76-81. doi: 10.1152/ajpgi.00053.2009. Epub 2009 May 21.
9
p65/RelA modulates BECN1 transcription and autophagy.p65/RelA调节Beclin 1转录和自噬。
Mol Cell Biol. 2009 May;29(10):2594-608. doi: 10.1128/MCB.01396-08. Epub 2009 Mar 16.
10
Reporter gene imaging of protein-protein interactions in living subjects.活体受试者中蛋白质-蛋白质相互作用的报告基因成像。
Curr Opin Biotechnol. 2007 Feb;18(1):31-7. doi: 10.1016/j.copbio.2007.01.007. Epub 2007 Jan 24.